BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pfeffer G, Chinnery PF. Diagnosis and treatment of mitochondrial myopathies. Ann Med 2013;45:4-16. [PMID: 21867371 DOI: 10.3109/07853890.2011.605389] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Birtel J, von Landenberg C, Gliem M, Gliem C, Reimann J, Kunz WS, Herrmann P, Betz C, Caswell R, Nesbitt V, Kornblum C, Issa PC. Mitochondrial Retinopathy. Ophthalmol Retina 2021:S2468-6530(21)00071-3. [PMID: 34257060 DOI: 10.1016/j.oret.2021.02.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Bird MJ, Wijeyeratne XW, Komen JC, Laskowski A, Ryan MT, Thorburn DR, Frazier AE. Neuronal and astrocyte dysfunction diverges from embryonic fibroblasts in the Ndufs4fky/fky mouse. Biosci Rep 2014;34:e00151. [PMID: 25312000 DOI: 10.1042/BSR20140151] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
3 Alpert NM, Guehl N, Ptaszek L, Pelletier-Galarneau M, Ruskin J, Mansour MC, Wooten D, Ma C, Takahashi K, Zhou Y, Shoup TM, Normandin MD, El Fakhri G. Quantitative in vivo mapping of myocardial mitochondrial membrane potential. PLoS One 2018;13:e0190968. [PMID: 29338024 DOI: 10.1371/journal.pone.0190968] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
4 Heighton JN, Brady LI, Newman MC, Tarnopolsky MA. Clinical and demographic features of chronic progressive external ophthalmoplegia in a large adult-onset cohort. Mitochondrion 2019;44:15-9. [DOI: 10.1016/j.mito.2017.12.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
5 Nabben M, Schmitz JPJ, Ciapaite J, le Clercq CMP, van Riel NA, Haak HR, Nicolay K, de Coo IFM, Smeets H, Praet SF, van Loon LJ, Prompers JJ. Dietary nitrate does not reduce oxygen cost of exercise or improve muscle mitochondrial function in patients with mitochondrial myopathy. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2017;312:R689-701. [DOI: 10.1152/ajpregu.00264.2016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hendrix CL, van den Heuvel FM, Rodwell L, Timmermans J, Nijveldt R, Janssen MC, Saris CG. Screening and prevalence of cardiac abnormalities on electro- and echocardiography in a large cohort of patients with mitochondrial disease. Molecular Genetics and Metabolism 2022. [DOI: 10.1016/j.ymgme.2022.05.004] [Reference Citation Analysis]
7 Dodd S, Fernandes BS, Dean OM. Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder. Curr Neuropharmacol 2015;13:656-62. [PMID: 26467413 DOI: 10.2174/1570159x13666150630175841] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 D'Arcy C, Hazrati LN, Chiasson DA. Histopathologic Analysis in Sudden Infant and Child Deaths: A Practical Approach. Acad Forensic Pathol 2018;8:492-538. [PMID: 31240057 DOI: 10.1177/1925362118797727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Omer S, Koumangoye R, Delpire E. A mutation in the Na-K-2Cl cotransporter-1 leads to changes in cellular metabolism. J Cell Physiol 2020;235:7239-50. [PMID: 32039487 DOI: 10.1002/jcp.29623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Díaz-Santiago E, Claros MG, Yahyaoui R, de Diego-Otero Y, Calvo R, Hoenicka J, Palau F, Ranea JAG, Perkins JR. Decoding Neuromuscular Disorders Using Phenotypic Clusters Obtained From Co-Occurrence Networks. Front Mol Biosci 2021;8:635074. [PMID: 34046427 DOI: 10.3389/fmolb.2021.635074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Nix JS, Moore SA. What Every Neuropathologist Needs to Know: The Muscle Biopsy. J Neuropathol Exp Neurol 2020;79:719-33. [PMID: 32529201 DOI: 10.1093/jnen/nlaa046] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Quadir A, Pontifex CS, Lee Robertson H, Labos C, Pfeffer G. Systematic review and meta-analysis of cardiac involvement in mitochondrial myopathy. Neurol Genet 2019;5:e339. [PMID: 31403078 DOI: 10.1212/NXG.0000000000000339] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Na JH, Kim HD, Lee YM. Effective and safe diet therapies for Lennox-Gastaut syndrome with mitochondrial dysfunction. Ther Adv Neurol Disord 2020;13:1756286419897813. [PMID: 32082420 DOI: 10.1177/1756286419897813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Kimoloi S. Modulation of the de novo purine nucleotide pathway as a therapeutic strategy in mitochondrial myopathy. Pharmacol Res 2018;138:37-42. [PMID: 30267763 DOI: 10.1016/j.phrs.2018.09.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Alpert NM, Pelletier-Galarneau M, Kim SJW, Petibon Y, Sun T, Ramos-Torres KM, Normandin MD, El Fakhri G. In-vivo Imaging of Mitochondrial Depolarization of Myocardium With Positron Emission Tomography and a Proton Gradient Uncoupler. Front Physiol 2020;11:491. [PMID: 32499721 DOI: 10.3389/fphys.2020.00491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Phadke R. Myopathology of Adult and Paediatric Mitochondrial Diseases. J Clin Med 2017;6:E64. [PMID: 28677615 DOI: 10.3390/jcm6070064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
17 Shapiro F, Athiraman U, Clendenin DJ, Hoagland M, Sethna NF, Veyckemans F. Anesthetic management of 877 pediatric patients undergoing muscle biopsy for neuromuscular disorders: a 20-year review. Paediatr Anaesth 2016;26:710-21. [DOI: 10.1111/pan.12909] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
18 Flickinger J, Fan J, Wellik A, Ganetzky R, Goldstein A, Muraresku CC, Glanzman AM, Ballance E, Leonhardt K, Mccormick EM, Soreth B, Nguyen S, Gornish J, George‐sankoh I, Peterson J, Macmullen LE, Vishnubhatt S, Mcbride M, Haas R, Falk MJ, Xiao R, Zolkipli‐cunningham Z. Development of a Mitochondrial Myopathy‐Composite Assessment Tool. JCSM Clinical Reports 2021;6:109-27. [DOI: 10.1002/crt2.41] [Reference Citation Analysis]
19 Mimura T, Imai S, Kawasaki T, Furuya Y, Mori K, Matsusue Y. Late-Emerging Lethal Exacerbation of Cardiomyopathy in a Patient with Mitochondrial Myopathy After Total Hip Arthroplasty: A Case Report. JBJS Case Connector 2014;4:e105. [DOI: 10.2106/jbjs.cc.n.00043] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Mkaouar-rebai E, Ben Mahmoud A, Chamkha I, Chabchoub I, Kammoun T, Hachicha M, Fakhfakh F. A novel MT-CO2 m.8249G > A pathogenic variation and the MT-TW m.5521G > A mutation in patients with mitochondrial myopathy. Mitochondrial DNA 2013;25:394-9. [DOI: 10.3109/19401736.2013.803086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
21 Almannai M, Alasmari A, Alqasmi A, Faqeih E, Al Mutairi F, Alotaibi M, Samman MM, Eyaid W, Aljadhai YI, Shamseldin HE, Craigen W, Alkuraya FS. Expanding the phenotype of SLC25A42-associated mitochondrial encephalomyopathy. Clin Genet 2018;93:1097-102. [PMID: 29327420 DOI: 10.1111/cge.13210] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
22 Pfeffer G, Povitz M, Gibson GJ, Chinnery PF. Diagnosis of muscle diseases presenting with early respiratory failure. J Neurol 2015;262:1101-14. [DOI: 10.1007/s00415-014-7526-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
23 Leung DG, Cohen JS, Michelle EH, Bai R, Mammen AL, Christopher-Stine L. Mitochondrial DNA Deletions With Low-Level Heteroplasmy in Adult-Onset Myopathy. J Clin Neuromuscul Dis 2018;19:117-23. [PMID: 29465611 DOI: 10.1097/CND.0000000000000200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
24 Florian A, Ludwig A, Stubbe-Dräger B, Boentert M, Young P, Waltenberger J, Rösch S, Sechtem U, Yilmaz A. Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy. J Cardiovasc Magn Reson 2015;17:40. [PMID: 26001801 DOI: 10.1186/s12968-015-0145-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
25 de Barcelos IP, Emmanuele V, Hirano M. Advances in primary mitochondrial myopathies. Curr Opin Neurol 2019;32:715-21. [PMID: 31408013 DOI: 10.1097/WCO.0000000000000743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Cicero AFG, Fogacci F, Bove M, Borghi C. Successful treatment of a patient with mitochondrial myopathy with alirocumab. J Clin Lipidol 2020;14:646-8. [PMID: 32800583 DOI: 10.1016/j.jacl.2020.07.007] [Reference Citation Analysis]
27 Polimeno L, Rossi R, Mastrodonato M, Montagnani M, Piscitelli D, Pesetti B, De Benedictis L, Girardi B, Resta L, Napoli A, Francavilla A. Augmenter of liver regeneration, a protective factor against ROS-induced oxidative damage in muscle tissue of mitochondrial myopathy affected patients. The International Journal of Biochemistry & Cell Biology 2013;45:2410-9. [DOI: 10.1016/j.biocel.2013.07.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
28 Li Z, Shen J, Liang J. Scoliosis in mitochondrial myopathy: case report and review of the literature. Medicine (Baltimore) 2015;94:e513. [PMID: 25674747 DOI: 10.1097/MD.0000000000000513] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Karaa A, Haas R, Goldstein A, Vockley J, Cohen BH. A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy. J Cachexia Sarcopenia Muscle 2020;11:909-18. [PMID: 32096613 DOI: 10.1002/jcsm.12559] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Hocaoglu H, Sieber M. Mitochondrial respiratory quiescence: A new model for examining the role of mitochondrial metabolism in development. Semin Cell Dev Biol 2022:S1084-9521(22)00122-7. [PMID: 35450766 DOI: 10.1016/j.semcdb.2022.03.040] [Reference Citation Analysis]
31 Korzeniewski B. Effect of training on skeletal muscle bioenergetic system in patients with mitochondrial myopathies: A computational study. Respir Physiol Neurobiol 2021;296:103799. [PMID: 34624544 DOI: 10.1016/j.resp.2021.103799] [Reference Citation Analysis]
32 Zhao X, Li A, Soni M, Muriello MJ, Jones CH, Whittier WL. McArdle disease: a "pediatric" disorder presenting in an adult with acute kidney injury. CEN Case Rep 2017;6:156-60. [PMID: 28660497 DOI: 10.1007/s13730-017-0265-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
33 Long JC, Best S, Hatem S, Theodorou T, Catton T, Murray S, Braithwaite J, Christodoulou J. The long and winding road: perspectives of people and parents of children with mitochondrial conditions negotiating management after diagnosis. Orphanet J Rare Dis 2021;16:310. [PMID: 34256797 DOI: 10.1186/s13023-021-01939-6] [Reference Citation Analysis]
34 Finsterer J, Bindu PS. Therapeutic strategies for mitochondrial disorders. Pediatr Neurol 2015;52:302-13. [PMID: 25701186 DOI: 10.1016/j.pediatrneurol.2014.06.023] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
35 Wahbi K, Bougouin W, Béhin A, Stojkovic T, Bécane HM, Jardel C, Berber N, Mochel F, Lombès A, Eymard B, Duboc D, Laforêt P. Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases. Eur Heart J 2015;36:2886-93. [DOI: 10.1093/eurheartj/ehv307] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
36 Mazzoni M, Soglia F, Petracci M, Sirri F, Lattanzio G, Clavenzani P. Fiber Metabolism, Procollagen and Collagen Type III Immunoreactivity in Broiler Pectoralis Major Affected by Muscle Abnormalities. Animals (Basel) 2020;10:E1081. [PMID: 32585889 DOI: 10.3390/ani10061081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Wang YX, Le WD. Progress in Diagnosing Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes. Chin Med J (Engl) 2015;128:1820-5. [PMID: 26112726 DOI: 10.4103/0366-6999.159360] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
38 Riuzzi F, Sorci G, Sagheddu R, Chiappalupi S, Salvadori L, Donato R. RAGE in the pathophysiology of skeletal muscle. J Cachexia Sarcopenia Muscle 2018;9:1213-34. [PMID: 30334619 DOI: 10.1002/jcsm.12350] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
39 Sofronova JK, Ilinsky YY, Orishchenko KE, Chupakhin EG, Lunev EA, Mazunin IO. Detection of Mutations in Mitochondrial DNA by Droplet Digital PCR. Biochemistry (Mosc) 2016;81:1031-7. [PMID: 27908228 DOI: 10.1134/S0006297916100011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
40 Hoh JFY. Myosin heavy chains in extraocular muscle fibres: Distribution, regulation and function. Acta Physiol (Oxf) 2021;231:e13535. [PMID: 32640094 DOI: 10.1111/apha.13535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
41 Grigoratos C, Todiere G, Barison A, Aquaro GD. The Role of MRI in Prognostic Stratification of Cardiomyopathies. Curr Cardiol Rep 2020;22:61. [PMID: 32562090 DOI: 10.1007/s11886-020-01311-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Tischner C, Wenz T. Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders. Mitochondrion 2015;24:32-49. [DOI: 10.1016/j.mito.2015.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
43 Herbst A, Aiken JM, McKenzie D, Wanagat J. Comment on: "Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging. Cells 2020, 9, 197". Cells 2020;9:E1796. [PMID: 32751058 DOI: 10.3390/cells9081796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Luo M, Zhou W, Patel H, Srivastava AP, Symersky J, Bonar MM, Faraldo-Gómez JD, Liao M, Mueller DM. Bedaquiline inhibits the yeast and human mitochondrial ATP synthases. Commun Biol 2020;3:452. [PMID: 32814813 DOI: 10.1038/s42003-020-01173-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
45 Kubo T, Kitaoka H. Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity. Curr Cardiol Rep. 2017;19:65. [PMID: 28639223 DOI: 10.1007/s11886-017-0875-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Scott Binder M, Roda RH, Corse AM, Sidhu S, Stewart S, Barth AS. Prevalence of heart disease in patients with mitochondrial abnormalities on skeletal muscle biopsy. Ann Clin Transl Neurol 2021;8:825-30. [PMID: 33638621 DOI: 10.1002/acn3.51327] [Reference Citation Analysis]
47 Set KK, Sen K, Huq AHM, Agarwal R. Mitochondrial Disorders of the Nervous System: A Review. Clin Pediatr (Phila) 2019;58:381-94. [PMID: 30607979 DOI: 10.1177/0009922818821890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Vásquez-trincado C, Dunn J, Han JI, Hymms B, Tamaroff J, Patel M, Nguyen S, Dedio A, Wade K, Enigwe C, Nichtova Z, Lynch DR, Csordas G, Mccormack SE, Seifert EL. Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle. JCI Insight 2022;7:e155201. [DOI: 10.1172/jci.insight.155201] [Reference Citation Analysis]
49 McInnes J. Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr Metab (Lond) 2013;10:63. [PMID: 24499129 DOI: 10.1186/1743-7075-10-63] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
50 Neels JG, Grimaldi PA. Physiological functions of peroxisome proliferator-activated receptor β. Physiol Rev 2014;94:795-858. [PMID: 24987006 DOI: 10.1152/physrev.00027.2013] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 12.0] [Reference Citation Analysis]
51 Sanchez B, Li J, Bragos R, Rutkove SB. Differentiation of the intracellular structure of slow- versus fast-twitch muscle fibers through evaluation of the dielectric properties of tissue. Phys Med Biol 2014;59:2369-80. [PMID: 24743385 DOI: 10.1088/0031-9155/59/10/2369] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
52 Lucas CG, Margeta M. Educational Case: Mitochondrial Myopathy. Acad Pathol 2019;6:2374289519888732. [PMID: 31828221 DOI: 10.1177/2374289519888732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Zhou Y, Yi J, Liu L, Wang X, Dong L, Du A. Acute mitochondrial myopathy with respiratory insufficiency and motor axonal polyneuropathy. Int J Neurosci 2018;128:231-6. [PMID: 28969510 DOI: 10.1080/00207454.2017.1387113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Menezes MJ, Riley LG, Christodoulou J. Mitochondrial respiratory chain disorders in childhood: Insights into diagnosis and management in the new era of genomic medicine. Biochimica et Biophysica Acta (BBA) - General Subjects 2014;1840:1368-79. [DOI: 10.1016/j.bbagen.2013.12.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
55 Maldonado EM, Taha F, Rahman J, Rahman S. Systems Biology Approaches Toward Understanding Primary Mitochondrial Diseases. Front Genet 2019;10:19. [PMID: 30774647 DOI: 10.3389/fgene.2019.00019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
56 Krieg E, Calderwood L, Campion M, Krepkovich KE. Confirmed versus suspected: The social significance of a genetic or non-genetic diagnosis of mitochondrial disease. Mitochondrion 2016;28:60-6. [PMID: 27017995 DOI: 10.1016/j.mito.2016.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Volobueva AS, Melnichenko AA, Grechko AV, Orekhov AN. Mitochondrial genome variability: the effect on cellular functional activity. Ther Clin Risk Manag 2018;14:237-45. [PMID: 29467576 DOI: 10.2147/TCRM.S153895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Mcclelland C, Manousakis G, Lee MS. Progressive External Ophthalmoplegia. Curr Neurol Neurosci Rep 2016;16. [DOI: 10.1007/s11910-016-0652-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
59 Papadopoulos C, Wahbi K, Behin A, Bougouin W, Stojkovic T, Leonard-Louis S, Berber N, Lombès A, Duboc D, Jardel C, Eymard B, Laforêt P. Incidence and predictors of total mortality in 267 adults presenting with mitochondrial diseases. J Inherit Metab Dis 2020;43:459-66. [PMID: 31652339 DOI: 10.1002/jimd.12185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
60 Koo P, Sethi JM. Metabolic Myopathies and the Respiratory System. Clin Chest Med 2018;39:401-10. [PMID: 29779598 DOI: 10.1016/j.ccm.2018.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
61 Korzeniewski B. Effects of OXPHOS complex deficiencies and ESA dysfunction in working intact skeletal muscle: implications for mitochondrial myopathies. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2015;1847:1310-9. [DOI: 10.1016/j.bbabio.2015.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
62 Jang DH, Kelly M, Hardy K, Lambert DS, Shofer FS, Eckmann DM. A preliminary study in the alterations of mitochondrial respiration in patients with carbon monoxide poisoning measured in blood cells. Clin Toxicol (Phila) 2017;55:579-84. [PMID: 28489460 DOI: 10.1080/15563650.2017.1288912] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
63 Kakoty V, K C S, Tang RD, Yang CH, Dubey SK, Taliyan R. Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease. Biomed Pharmacother 2020;127:110145. [PMID: 32361164 DOI: 10.1016/j.biopha.2020.110145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
64 Komen JC, Thorburn DR. Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models. Br J Pharmacol 2014;171:1818-36. [PMID: 24102298 DOI: 10.1111/bph.12413] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]
65 Groh WJ, Bhakta D, Tomaselli GF, Aleong RG, Teixeira RA, Amato A, Asirvatham SJ, Cha YM, Corrado D, Duboc D, Goldberger ZD, Horie M, Hornyak JE, Jefferies JL, Kääb S, Kalman JM, Kertesz NJ, Lakdawala NK, Lambiase PD, Lubitz SA, McMillan HJ, McNally EM, Milone M, Namboodiri N, Nazarian S, Patton KK, Russo V, Sacher F, Santangeli P, Shen WK, Sobral Filho DC, Stambler BS, Stöllberger C, Wahbi K, Wehrens XHT, Weiner MM, Wheeler MT, Zeppenfeld K. 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders. Heart Rhythm 2022:S1547-5271(22)01946-4. [PMID: 35500790 DOI: 10.1016/j.hrthm.2022.04.022] [Reference Citation Analysis]
66 Gimenes AC, Bravo DM, Nápolis LM, Mello MT, Oliveira AS, Neder JA, Nery LE. Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy. Braz J Med Biol Res 2015;48:354-62. [PMID: 25714882 DOI: 10.1590/1414-431X20143467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
67 Chen Y, Luo P, Li Z, Hu H, Wu D, Xu T, Wang X, Xie H. Kennedy disease with difficulty in differential diagnosis: A case report. Medicine (Baltimore) 2017;96:e6792. [PMID: 28489755 DOI: 10.1097/MD.0000000000006792] [Reference Citation Analysis]
68 Ponsiglione A, Ascione R, Nappi C, Imbriaco M, Klain M, Cuocolo R, Cuocolo A, Petretta M. Cardiac hybrid imaging: novel tracers for novel targets. J Geriatr Cardiol 2021;18:748-58. [PMID: 34659381 DOI: 10.11909/j.issn.1671-5411.2021.09.006] [Reference Citation Analysis]
69 Wali G, Kumar KR, Liyanage E, Davis RL, Mackay-Sim A, Sue CM. Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in SPG7 but Not SPAST Patient-Derived Stem Cells. Front Neurosci 2020;14:820. [PMID: 32973427 DOI: 10.3389/fnins.2020.00820] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Wallace DC. Mitochondrial genetic medicine. Nat Genet 2018;50:1642-9. [PMID: 30374071 DOI: 10.1038/s41588-018-0264-z] [Cited by in Crossref: 101] [Cited by in F6Publishing: 93] [Article Influence: 25.3] [Reference Citation Analysis]
71 Korzeniewski B. Faster and stronger manifestation of mitochondrial diseases in skeletal muscle than in heart related to cytosolic inorganic phosphate (Pi) accumulation. J Appl Physiol (1985) 2016;121:424-37. [PMID: 27283913 DOI: 10.1152/japplphysiol.00358.2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
72 Tobon A. Metabolic myopathies. Continuum (Minneap Minn) 2013;19:1571-97. [PMID: 24305448 DOI: 10.1212/01.CON.0000440660.41675.06] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
73 Naresh NU, Haynes CM. Signaling and Regulation of the Mitochondrial Unfolded Protein Response. Cold Spring Harb Perspect Biol 2019;11:a033944. [PMID: 30617048 DOI: 10.1101/cshperspect.a033944] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
74 Saoji M, Petersen CE, Sen A, Tripoli BA, Smyth JT, Cox RT. Reduction of Drosophila Mitochondrial RNase P in Skeletal and Heart Muscle Causes Muscle Degeneration, Cardiomyopathy, and Heart Arrhythmia. Front Cell Dev Biol 2022;10:788516. [DOI: 10.3389/fcell.2022.788516] [Reference Citation Analysis]
75 Boentert M, Wenninger S, Sansone VA. Respiratory involvement in neuromuscular disorders. Curr Opin Neurol 2017;30:529-37. [PMID: 28562381 DOI: 10.1097/WCO.0000000000000470] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
76 Shin J, Kim D. Genetics of Mitochondrial Myopathies. J Genet Med 2013;10:20-6. [DOI: 10.5734/jgm.2013.10.1.20] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
77 Van Driessche K, Ducatelle R, Chiers K, Van Coster R, van der Kolk JH. Ultrastructural mitochondrial alterations in equine myopathies of unknown origin. Vet Q 2015;35:2-8. [PMID: 25365353 DOI: 10.1080/01652176.2015.983681] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
78 Korzeniewski B. Mechanisms of the effect of oxidative phosphorylation deficiencies on the skeletal muscle bioenergetic system in patients with mitochondrial myopathies. J Appl Physiol (1985) 2021;131:768-77. [PMID: 34197225 DOI: 10.1152/japplphysiol.00196.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Sharma G, Pfeffer G, Shutt TE. Genetic Neuropathy Due to Impairments in Mitochondrial Dynamics. Biology (Basel) 2021;10:268. [PMID: 33810506 DOI: 10.3390/biology10040268] [Reference Citation Analysis]
80 Bisceglia M, Crociani P, Fogli D, Centola A, Galliani CA, Pasquinelli G. Selected case from the Arkadi M. Rywlin International Pathology Slide Series: Mitochondrial myopathy presenting with chronic progressive external ophthalmoplegia (CPEO): a case report. Adv Anat Pathol 2014;21:461-8. [PMID: 25299315 DOI: 10.1097/PAP.0000000000000045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Pan X, Wang L, Fei G, Dong J, Zhong C, Lu J, Jin L. Acute Respiratory Failure Is the Initial Manifestation in the Adult-Onset A3243G tRNALeu mtDNA Mutation: A Case Report and the Literature Review. Front Neurol 2019;10:780. [PMID: 31379729 DOI: 10.3389/fneur.2019.00780] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]